Year-over-year, this metric declined by 424.1%, from $112.00M to -$363.00M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows a downward trend with a -64.3% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.04B | $3.14B | $2.83B | $4.01B | $4.04B | $4.09B | $4.00B | $2.00B | $2.11B | $2.25B | $1.58B | $201.00M | $923.00M | $1.01B | $751.00M | $1.37B | $112.00M | $1.00M | $98.00M | $0.00 | -$363.00M |
| QoQ Change | — | +3.2% | -9.9% | +42.1% | +0.6% | +1.3% | -2.2% | -50.1% | +5.5% | +6.8% | -29.7% | -87.3% | +359.2% | +9.1% | -25.4% | +82.7% | -91.8% | -99.1% | >999% | -100.0% | — |
| YoY Change | — | — | — | — | +32.9% | +30.5% | +41.6% | -50.2% | -47.8% | -45.0% | -60.5% | -89.9% | -56.2% | -55.2% | -52.5% | +582.6% | -87.9% | -99.9% | -87.0% | -100.0% | -424.1% |